Posts Tagged ‘precision medicine’

Drug Studies, Labels, and Dosing Only for Lean Persons?

November 8, 2023 — Public health experts have long been accounting for it. People are living in larger bodies. Better than 40% of U.S. adults have a body weight in the range of obesity. But new reporting from JoNel Aleccia for the Associated Press tells us that pharma and the FDA are not yet accounting for this fact. It’s […]

Homogeneous Policies for a Heterogeneous Disease

March 29, 2022 — For decades now, health policy advocates have been pursuing a solution to the growing effects of obesity on public health. The banners shift over time, but the goal is pretty consistent. It’s better diets and more physical activity across the population to reverse the trend in obesity prevalence. Low fat everything! Let’s Move! Tax and […]

The Art and Science of Precision Medicine for Obesity

March 31, 2021 — Editors note: after this post appeared, significant questions arose about errors in the Acosta paper described below. We will offer more information when more is available. Update June 23, 2021: The journal has published a correction, making clear that this study was not randomized nor did it have a pre-registered protocol and leaving us with […]

Innovative Health Tech in the Toilet

December 21, 2019 — The future is in the toilet. Fitbits are passé. Smart watches have hit their peak. But real health tech innovation is coming to your toilet. Are you ready? Toilet Bowl Metabolomics This is no joke. In NPJ Digital Medicine, Ian Miller and colleagues describe the technology to bring metabolomics to your toilet. They propose a […]

On the Hunt for Precision Personalized Diets

March 13, 2019 — Precision nutrition is a concept with an almost irresistible allure. It borrows on the cachet of precision medicine. On top of that, frustration with the presently imprecise nature of nutrition science makes the promise of precision personalized diets especially appealing. So in pursuit of this idea, a new study in Nutrients offers some tantalizing clues. […]

More Progress with a Super Targeted Obesity Drug

May 11, 2018 — Two years ago, Rhythm Pharmaceuticals made a big splash with a study showing impressive efficacy for their super targeted obesity drug, setmelanotide. That paper in the New England Journal of Medicine showed setmelanotide could reverse obesity in patients with a rare POMC gene defect. Now, researchers have published new data showing promise in patients with […]